NSE · NH
Narayana Hrudayalaya Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,097 Cr with net profit ₹138 Cr — a 12.57% net margin, versus 10.07% the period before.
Shareholding
As of 2026-06-30
- Promoter63.27%
- Public18.27%
- FII9.4%
- DII9.06%
2,11,173 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.32× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #7 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,27,968 Cr | 60.82 | 13.5 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,01,088 Cr | 67.53 | 9.41 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹96,450 Cr | 102.84 | 5.87 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹68,131 Cr | 63.87 | 6.89 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,888 Cr | 172.44 | 15.9 | 8.48% | 6.54% |
| Global Health Limited | ₹39,245 Cr | 68.56 | 9.91 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd.(this company) | ₹39,027 Cr | 45.28 | 8.6 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹32,458 Cr | 155.49 | 8.66 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,172 Cr | 57.2 | 12.83 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,743 Cr | 55.45 | 5.71 | 10.37% | 15.77% |
AI analysis
AI-generated · google/gemini-2.5-flashNarayana Hrudayalaya Ltd. operates in the Healthcare sector. The company has a market capitalisation of Rs 40825 Cr. As of Mar 2025, its annual revenue was Rs 5575.012 Cr, with a net profit of Rs 790.155 Cr. The Earnings Per Share (EPS) as of Mar 2025 was Rs 38.9, while the latest reported EPS is Rs 41.68.
Positives
- +The profit margin is 10.2%.
- +Return on Equity (ROE) is 17.76%.
- +Promoter holding of 63.2747% as of June 30, 2026 is high.
- +Promoter pledge is 0%, indicating no shares are pledged.
Negatives
- −The trailing PE ratio of 181.28 is high relative to its EPS of Rs 41.68.
- −The dividend yield is 23%, which may be unsustainable.
- −Quarterly results are not disclosed since Mar 2026.
Financial performance
Narayana Hrudayalaya Ltd. reported an annual revenue of Rs 5575.012 Cr in Mar 2025, and a net profit of Rs 790.155 Cr. Quarterly revenue for Mar 2026 was Rs 2593.81 Cr, representing a growth of 12.12%. Net profit for the same quarter was Rs 223.88 Cr.
Profitability & Returns
The company's profit margin stood at 10.2%. Return on Equity (ROE) was 17.76%, and Return on Capital Employed (ROCE) was 11.4186%. The diluted EPS is Rs 41.68 with a PE ratio of 181.28.
Balance Sheet
The company has a Book Value of Rs 222.02. The debt-to-equity ratio is 0.62, indicating its leverage. No further details on assets or liabilities are available from the provided data.
Ownership & Pledges
Public shareholding is 18.2684%, with institutional holding at 18.4569%. There is no promoter pledge reported.
Regulatory & Surveillance
No information regarding any regulatory actions or inclusion on a surveillance list has been provided for Narayana Hrudayalaya Ltd. This suggests the company is not currently under specific regulatory scrutiny based on the available data.
Data as of — price: 2026-09-10 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.